Moat Ross sold KNSA
April 6, 2026 · Form 4 insider transaction
Moat Ross sold 2,367 shares of Kiniksa Pharmaceuticals International, plc at $48.58 per share, a transaction worth $115.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,367
Price
$48.58
Total value
$115.0K
InsiderMoat Ross
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeS: Open-market sale
Transaction dateApril 6, 2026
Filing dateApril 8, 2026
Shares owned after12,029
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on November 13, 2024.